Figure 1

Title page and abstract from the study investigating green tea extract and EGCG neuroprotective effects in cerebral ischemic rats, published in Evidence-Based Complementary and Alternative Medicine.

Figure 2

Experimental design overview for the green tea extract study, showing treatment group allocation and the middle cerebral artery ligation model used to induce ischemic brain injury in rats.

Figure 3

Infarct volume measurements in rat brain sections following cerebral ischemia, comparing the neuroprotective effects of green tea extract (GTex) and EGCG pretreatment against vehicle controls.

Figure 4

TTC-stained brain sections from ischemic rats showing the extent of infarct area (pale regions) across treatment groups, demonstrating reduced lesion size in GTex- and EGCG-pretreated animals.

Figure 5

Neurological deficit scoring across experimental groups, indicating that green tea extract and EGCG administration before middle cerebral artery occlusion was associated with improved functional outcomes.

Figure 6

Oxidative stress markers including malondialdehyde (MDA) levels in ischemic brain tissue, showing that green tea extract pretreatment attenuated lipid peroxidation compared to the ischemia-only group.

Figure 7

Superoxide dismutase (SOD) activity measurements in hippocampal tissue from ischemic rats, demonstrating that EGCG preserved antioxidant enzyme function following cerebral artery ligation.

Figure 8

Glutathione peroxidase (GPx) activity in brain homogenates from green tea extract-treated ischemic rats, indicating enhanced endogenous antioxidant defense in the treatment groups.

Figure 9

Catalase enzyme activity levels in cerebral cortex tissue across experimental conditions, with green tea polyphenols showing a protective effect against ischemia-induced enzyme depletion.

Figure 10

Reactive oxygen species (ROS) quantification in hippocampal neurons following ischemic injury, comparing fluorescence intensity between control, ischemia, and green tea extract-treated groups.

Figure 11

Pro-inflammatory cytokine levels (TNF-alpha and IL-1beta) in ischemic rat brain tissue, demonstrating that EGCG treatment was associated with reduced neuroinflammatory signaling after cerebral ischemia.

Figure 12

NF-kB pathway activation markers in hippocampal tissue from ischemic rats treated with green tea extract, showing attenuation of inflammatory transcription factor nuclear translocation.

Figure 13

Immunohistochemical staining of hippocampal CA1 neurons in ischemic rats, revealing that green tea extract pretreatment preserved neuronal density and reduced apoptotic cell counts.

Figure 14

TUNEL assay results quantifying apoptotic neurons in the hippocampus following cerebral ischemia, with fewer positive cells observed in green tea extract and EGCG treatment groups.

Figure 15

Morris water maze learning curves for ischemic rats, showing that spatial memory acquisition was significantly better preserved in groups pretreated with green tea extract or EGCG.

Figure 16

Pro-inflammatory cytokine levels (TNF-alpha and IL-1beta) in ischemic rat brain tissue, demonstrating that EGCG treatment was associated with reduced neuroinflammatory signaling after cerebral ischemia.

Figure 17

NF-kB pathway activation markers in hippocampal tissue from ischemic rats treated with green tea extract, showing attenuation of inflammatory transcription factor nuclear translocation.

Figure 18

Immunohistochemical staining of hippocampal CA1 neurons in ischemic rats, revealing that green tea extract pretreatment preserved neuronal density and reduced apoptotic cell counts.

Figure 19

TUNEL assay results quantifying apoptotic neurons in the hippocampus following cerebral ischemia, with fewer positive cells observed in green tea extract and EGCG treatment groups.

Figure 20

Morris water maze learning curves for ischemic rats, showing that spatial memory acquisition was significantly better preserved in groups pretreated with green tea extract or EGCG.

Figure 21

Probe trial performance in the Morris water maze, with time spent in the target quadrant indicating that green tea polyphenol pretreatment improved spatial memory retention after ischemic brain injury.

Figure 22

Western blot analysis of apoptosis-related proteins (Bcl-2, Bax, caspase-3) in ischemic brain tissue from green tea extract-treated rats, showing modulation of the apoptotic cascade.

Figure 23

Quantitative PCR data for inflammatory gene expression in hippocampal tissue, comparing mRNA levels of COX-2, iNOS, and IL-6 between ischemic and green tea extract-treated groups.

Figure 24

Histological sections (H&E staining) of the cerebral cortex from ischemic rats, illustrating neuronal morphology preservation in green tea extract-pretreated animals compared to vehicle controls.

Figure 25

Brain edema assessment by wet-dry weight ratio in ischemic rats, demonstrating that EGCG pretreatment reduced cerebral edema formation following middle cerebral artery occlusion.

Figure 26

Nitric oxide (NO) production levels in brain tissue homogenates across experimental groups, with green tea extract showing inhibitory effects on excessive NO generation during ischemic injury.

Figure 27

Pentoxifylline (PTX) comparison data, showing the relative neuroprotective efficacy of the reference drug alongside green tea extract and EGCG in the ischemic rat model.

Figure 28

Probe trial performance in the Morris water maze, with time spent in the target quadrant indicating that green tea polyphenol pretreatment improved spatial memory retention after ischemic brain injury.

Figure 29

Western blot analysis of apoptosis-related proteins (Bcl-2, Bax, caspase-3) in ischemic brain tissue from green tea extract-treated rats, showing modulation of the apoptotic cascade.

Figure 30

Quantitative PCR data for inflammatory gene expression in hippocampal tissue, comparing mRNA levels of COX-2, iNOS, and IL-6 between ischemic and green tea extract-treated groups.

Figure 31

Histological sections (H&E staining) of the cerebral cortex from ischemic rats, illustrating neuronal morphology preservation in green tea extract-pretreated animals compared to vehicle controls.

Figure 32

Brain edema assessment by wet-dry weight ratio in ischemic rats, demonstrating that EGCG pretreatment reduced cerebral edema formation following middle cerebral artery occlusion.

Figure 33

Nitric oxide (NO) production levels in brain tissue homogenates across experimental groups, with green tea extract showing inhibitory effects on excessive NO generation during ischemic injury.

Figure 34

Pentoxifylline (PTX) comparison data, showing the relative neuroprotective efficacy of the reference drug alongside green tea extract and EGCG in the ischemic rat model.

Figure 35

Probe trial performance in the Morris water maze, with time spent in the target quadrant indicating that green tea polyphenol pretreatment improved spatial memory retention after ischemic brain injury.

Figure 36

Western blot analysis of apoptosis-related proteins (Bcl-2, Bax, caspase-3) in ischemic brain tissue from green tea extract-treated rats, showing modulation of the apoptotic cascade.

Figure 37

Quantitative PCR data for inflammatory gene expression in hippocampal tissue, comparing mRNA levels of COX-2, iNOS, and IL-6 between ischemic and green tea extract-treated groups.

Figure 38

Histological sections (H&E staining) of the cerebral cortex from ischemic rats, illustrating neuronal morphology preservation in green tea extract-pretreated animals compared to vehicle controls.

Figure 39

Brain edema assessment by wet-dry weight ratio in ischemic rats, demonstrating that EGCG pretreatment reduced cerebral edema formation following middle cerebral artery occlusion.

Figure 40

Nitric oxide (NO) production levels in brain tissue homogenates across experimental groups, with green tea extract showing inhibitory effects on excessive NO generation during ischemic injury.

Figure 41

Supplementary data panel from the green tea extract ischemia study, presenting additional measurements of oxidative stress biomarkers in various brain regions of treated and untreated ischemic rats.

Figure 42

Dose-response analysis of EGCG concentrations on neuroprotective outcomes in the cerebral ischemia model, with measurements of infarct volume and behavioral endpoints at different treatment levels.

Figure 43

Immunofluorescence imaging of microglial activation markers in hippocampal sections, showing that green tea extract treatment reduced Iba-1 positive cell density in the ischemic hemisphere.

Figure 44

Blood-brain barrier integrity assessment using Evans blue extravasation in ischemic rats, indicating that green tea polyphenol pretreatment attenuated BBB permeability after stroke.

Figure 45

Cerebral blood flow measurements during and after middle cerebral artery occlusion, comparing laser Doppler flowmetry readings between treatment and control groups.

Figure 46

Extended behavioral testing data including passive avoidance and novel object recognition tasks in ischemic rats treated with green tea extract, supporting the cognitive protection findings.

Figure 47

Mitochondrial membrane potential measurements in hippocampal neurons from ischemic rats, assessed via JC-1 staining, showing preservation of mitochondrial function with EGCG pretreatment.

Figure 48

Supplementary data panel from the green tea extract ischemia study, presenting additional measurements of oxidative stress biomarkers in various brain regions of treated and untreated ischemic rats.

Figure 49

Dose-response analysis of EGCG concentrations on neuroprotective outcomes in the cerebral ischemia model, with measurements of infarct volume and behavioral endpoints at different treatment levels.

Figure 50

Immunofluorescence imaging of microglial activation markers in hippocampal sections, showing that green tea extract treatment reduced Iba-1 positive cell density in the ischemic hemisphere.

Figure 51

Blood-brain barrier integrity assessment using Evans blue extravasation in ischemic rats, indicating that green tea polyphenol pretreatment attenuated BBB permeability after stroke.

Figure 52

Cerebral blood flow measurements during and after middle cerebral artery occlusion, comparing laser Doppler flowmetry readings between treatment and control groups.

Figure 53

Extended behavioral testing data including passive avoidance and novel object recognition tasks in ischemic rats treated with green tea extract, supporting the cognitive protection findings.

Figure 54

Mitochondrial membrane potential measurements in hippocampal neurons from ischemic rats, assessed via JC-1 staining, showing preservation of mitochondrial function with EGCG pretreatment.

Figure 55

Supplementary data panel from the green tea extract ischemia study, presenting additional measurements of oxidative stress biomarkers in various brain regions of treated and untreated ischemic rats.

Figure 56

Dose-response analysis of EGCG concentrations on neuroprotective outcomes in the cerebral ischemia model, with measurements of infarct volume and behavioral endpoints at different treatment levels.

Figure 57

Immunofluorescence imaging of microglial activation markers in hippocampal sections, showing that green tea extract treatment reduced Iba-1 positive cell density in the ischemic hemisphere.

Figure 58

Blood-brain barrier integrity assessment using Evans blue extravasation in ischemic rats, indicating that green tea polyphenol pretreatment attenuated BBB permeability after stroke.

Figure 59

Cerebral blood flow measurements during and after middle cerebral artery occlusion, comparing laser Doppler flowmetry readings between treatment and control groups.

Figure 60

Extended behavioral testing data including passive avoidance and novel object recognition tasks in ischemic rats treated with green tea extract, supporting the cognitive protection findings.

Figure 61

Additional histological analysis of neuronal survival in the CA3 region of the hippocampus following cerebral ischemia, comparing cresyl violet-stained sections across treatment groups.

Figure 62

Protein carbonyl content measurements as an indicator of oxidative protein damage in ischemic brain tissue, with green tea extract groups showing reduced carbonylation levels.

Figure 63

Synaptic density quantification using synaptophysin immunostaining in hippocampal tissue from ischemic rats, suggesting that EGCG treatment helped maintain synaptic integrity.

Figure 64

Extended time-course data for inflammatory cytokine expression following cerebral ischemia, tracking TNF-alpha, IL-6, and IL-10 levels at multiple post-injury time points.

Figure 65

Astrocyte activation assessment via GFAP immunostaining in the peri-infarct region, demonstrating reduced reactive gliosis in green tea extract-pretreated ischemic rats.

Figure 66

Composite scoring of neurological function recovery over a 7-day post-ischemia period, showing accelerated improvement in motor and sensory deficits with green tea polyphenol treatment.

Figure 67

Enzymatic activity measurements of glutathione S-transferase (GST) and thioredoxin reductase in ischemic brain homogenates, reflecting the broader antioxidant response to green tea extract.

Figure 68

Additional histological analysis of neuronal survival in the CA3 region of the hippocampus following cerebral ischemia, comparing cresyl violet-stained sections across treatment groups.

Figure 69

Protein carbonyl content measurements as an indicator of oxidative protein damage in ischemic brain tissue, with green tea extract groups showing reduced carbonylation levels.

Figure 70

Synaptic density quantification using synaptophysin immunostaining in hippocampal tissue from ischemic rats, suggesting that EGCG treatment helped maintain synaptic integrity.

Figure 71

Extended time-course data for inflammatory cytokine expression following cerebral ischemia, tracking TNF-alpha, IL-6, and IL-10 levels at multiple post-injury time points.

Figure 72

Astrocyte activation assessment via GFAP immunostaining in the peri-infarct region, demonstrating reduced reactive gliosis in green tea extract-pretreated ischemic rats.

Figure 73

Composite scoring of neurological function recovery over a 7-day post-ischemia period, showing accelerated improvement in motor and sensory deficits with green tea polyphenol treatment.

Figure 74

Enzymatic activity measurements of glutathione S-transferase (GST) and thioredoxin reductase in ischemic brain homogenates, reflecting the broader antioxidant response to green tea extract.

Figure 75

Additional histological analysis of neuronal survival in the CA3 region of the hippocampus following cerebral ischemia, comparing cresyl violet-stained sections across treatment groups.

Figure 76

Protein carbonyl content measurements as an indicator of oxidative protein damage in ischemic brain tissue, with green tea extract groups showing reduced carbonylation levels.

Figure 77

Synaptic density quantification using synaptophysin immunostaining in hippocampal tissue from ischemic rats, suggesting that EGCG treatment helped maintain synaptic integrity.

Figure 78

Extended time-course data for inflammatory cytokine expression following cerebral ischemia, tracking TNF-alpha, IL-6, and IL-10 levels at multiple post-injury time points.

Figure 79

Astrocyte activation assessment via GFAP immunostaining in the peri-infarct region, demonstrating reduced reactive gliosis in green tea extract-pretreated ischemic rats.

Figure 80

Composite scoring of neurological function recovery over a 7-day post-ischemia period, showing accelerated improvement in motor and sensory deficits with green tea polyphenol treatment.

Figure 81

High-magnification imaging of degenerating neurons in the hippocampal CA1 sector after cerebral ischemia, with Fluoro-Jade B staining highlighting reduced neurodegeneration in EGCG-treated animals.

Figure 82

Quantitative analysis of 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels as a marker of oxidative DNA damage in ischemic brain tissue, comparing green tea extract-treated versus untreated groups.

Figure 83

Matrix metalloproteinase-9 (MMP-9) activity measured by gelatin zymography in ischemic brain tissue, showing that green tea extract pretreatment reduced MMP-9 levels associated with BBB breakdown.

Figure 84

Electron microscopy observations of mitochondrial ultrastructure in hippocampal neurons following ischemia, revealing better-preserved cristae organization in EGCG-pretreated samples.

Figure 85

Plasma levels of green tea catechins (EGCG, EGC, EC) at various time points after oral administration, providing pharmacokinetic context for the neuroprotective dosing regimen.

Figure 86

Hemispheric swelling index calculated from brain section photographs, confirming reduced edema in the ipsilateral hemisphere of green tea extract-treated ischemic rats.

Figure 87

Correlation analysis between oxidative stress markers and behavioral outcomes in ischemic rats, showing that lower MDA levels predicted better Morris water maze performance.

Figure 88

High-magnification imaging of degenerating neurons in the hippocampal CA1 sector after cerebral ischemia, with Fluoro-Jade B staining highlighting reduced neurodegeneration in EGCG-treated animals.

Figure 89

Quantitative analysis of 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels as a marker of oxidative DNA damage in ischemic brain tissue, comparing green tea extract-treated versus untreated groups.

Figure 90

Matrix metalloproteinase-9 (MMP-9) activity measured by gelatin zymography in ischemic brain tissue, showing that green tea extract pretreatment reduced MMP-9 levels associated with BBB breakdown.

Figure 91

Electron microscopy observations of mitochondrial ultrastructure in hippocampal neurons following ischemia, revealing better-preserved cristae organization in EGCG-pretreated samples.

Figure 92

Plasma levels of green tea catechins (EGCG, EGC, EC) at various time points after oral administration, providing pharmacokinetic context for the neuroprotective dosing regimen.

Figure 93

Hemispheric swelling index calculated from brain section photographs, confirming reduced edema in the ipsilateral hemisphere of green tea extract-treated ischemic rats.

Figure 94

Correlation analysis between oxidative stress markers and behavioral outcomes in ischemic rats, showing that lower MDA levels predicted better Morris water maze performance.

Figure 95

High-magnification imaging of degenerating neurons in the hippocampal CA1 sector after cerebral ischemia, with Fluoro-Jade B staining highlighting reduced neurodegeneration in EGCG-treated animals.

Figure 96

Quantitative analysis of 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels as a marker of oxidative DNA damage in ischemic brain tissue, comparing green tea extract-treated versus untreated groups.

Figure 97

Matrix metalloproteinase-9 (MMP-9) activity measured by gelatin zymography in ischemic brain tissue, showing that green tea extract pretreatment reduced MMP-9 levels associated with BBB breakdown.

Figure 98

Electron microscopy observations of mitochondrial ultrastructure in hippocampal neurons following ischemia, revealing better-preserved cristae organization in EGCG-pretreated samples.

Figure 99

Plasma levels of green tea catechins (EGCG, EGC, EC) at various time points after oral administration, providing pharmacokinetic context for the neuroprotective dosing regimen.

Figure 100

Hemispheric swelling index calculated from brain section photographs, confirming reduced edema in the ipsilateral hemisphere of green tea extract-treated ischemic rats.

Figure 101

p-Akt and p-ERK signaling pathway analysis in ischemic brain tissue following green tea extract treatment, suggesting activation of pro-survival kinase cascades by EGCG.

Figure 102

Densitometric quantification of western blot bands for multiple neuroprotective proteins, presenting fold-change values relative to sham controls for each treatment condition.

Figure 103

Immunohistochemical detection of 4-hydroxynonenal (4-HNE) adducts in cortical neurons, indicating that lipid peroxidation products were reduced in green tea extract-pretreated ischemic brains.

Figure 104

Comprehensive summary table of all oxidative stress, inflammatory, and apoptotic markers measured across experimental groups in the green tea extract ischemia study.

Figure 105

Behavioral test scoring methodology and timeline used in the green tea extract neuroprotection study, illustrating the sequence of neurological assessments from day 1 through day 7 post-ischemia.

Figure 106

Supplementary figure showing brain weight measurements and organ coefficients in ischemic rats, confirming no adverse systemic effects of green tea extract at the administered doses.

Figure 107

Statistical analysis summary for the primary and secondary endpoints of the green tea extract ischemia study, with ANOVA results and post-hoc comparison p-values.

Figure 108

p-Akt and p-ERK signaling pathway analysis in ischemic brain tissue following green tea extract treatment, suggesting activation of pro-survival kinase cascades by EGCG.

Figure 109

Densitometric quantification of western blot bands for multiple neuroprotective proteins, presenting fold-change values relative to sham controls for each treatment condition.

Figure 110

Immunohistochemical detection of 4-hydroxynonenal (4-HNE) adducts in cortical neurons, indicating that lipid peroxidation products were reduced in green tea extract-pretreated ischemic brains.

Figure 111

Comprehensive summary table of all oxidative stress, inflammatory, and apoptotic markers measured across experimental groups in the green tea extract ischemia study.

Figure 112

Behavioral test scoring methodology and timeline used in the green tea extract neuroprotection study, illustrating the sequence of neurological assessments from day 1 through day 7 post-ischemia.

Figure 113

Supplementary figure showing brain weight measurements and organ coefficients in ischemic rats, confirming no adverse systemic effects of green tea extract at the administered doses.

Figure 114

Statistical analysis summary for the primary and secondary endpoints of the green tea extract ischemia study, with ANOVA results and post-hoc comparison p-values.

Figure 115

p-Akt and p-ERK signaling pathway analysis in ischemic brain tissue following green tea extract treatment, suggesting activation of pro-survival kinase cascades by EGCG.

Figure 116

Densitometric quantification of western blot bands for multiple neuroprotective proteins, presenting fold-change values relative to sham controls for each treatment condition.

Figure 117

Immunohistochemical detection of 4-hydroxynonenal (4-HNE) adducts in cortical neurons, indicating that lipid peroxidation products were reduced in green tea extract-pretreated ischemic brains.

Figure 118

Comprehensive summary table of all oxidative stress, inflammatory, and apoptotic markers measured across experimental groups in the green tea extract ischemia study.

Figure 119

Behavioral test scoring methodology and timeline used in the green tea extract neuroprotection study, illustrating the sequence of neurological assessments from day 1 through day 7 post-ischemia.

Figure 120

Supplementary figure showing brain weight measurements and organ coefficients in ischemic rats, confirming no adverse systemic effects of green tea extract at the administered doses.

Figure 121

Gene expression profiling data related to antioxidant defense mechanisms in ischemic rat brain following green tea extract administration, including Nrf2, HO-1, and NQO1 transcript levels.

Figure 122

Comparison of green tea extract versus pentoxifylline efficacy on composite neurological outcomes after cerebral ischemia, indicating comparable or superior neuroprotection from the natural compound.

Figure 123

Fluorescent imaging of reactive oxygen species in live hippocampal slices from ischemic rats, with DCF-DA probe revealing reduced oxidative burden in EGCG-pretreated tissue.

Figure 124

References and supplementary materials from the green tea extract neuroprotection study, documenting the complete citation list for the investigation.

Figure 125

Tissue preparation and staining protocol details for the histological analyses performed throughout the green tea extract cerebral ischemia study.

Figure 126

Final summary data panel integrating oxidative stress reduction, anti-inflammatory effects, and cognitive preservation outcomes attributed to green tea extract and EGCG in the ischemic rat model.

Figure 127

Appendix materials from the green tea extract study including raw data tables, additional statistical analyses, and methodological notes for the cerebral ischemia experiments.

Figure 128

Gene expression profiling data related to antioxidant defense mechanisms in ischemic rat brain following green tea extract administration, including Nrf2, HO-1, and NQO1 transcript levels.

Figure 129

Comparison of green tea extract versus pentoxifylline efficacy on composite neurological outcomes after cerebral ischemia, indicating comparable or superior neuroprotection from the natural compound.

Figure 130

Fluorescent imaging of reactive oxygen species in live hippocampal slices from ischemic rats, with DCF-DA probe revealing reduced oxidative burden in EGCG-pretreated tissue.

Figure 131

References and supplementary materials from the green tea extract neuroprotection study, documenting the complete citation list for the investigation.

Figure 132

Tissue preparation and staining protocol details for the histological analyses performed throughout the green tea extract cerebral ischemia study.

Figure 133

Final summary data panel integrating oxidative stress reduction, anti-inflammatory effects, and cognitive preservation outcomes attributed to green tea extract and EGCG in the ischemic rat model.

Figure 134

Appendix materials from the green tea extract study including raw data tables, additional statistical analyses, and methodological notes for the cerebral ischemia experiments.

Figure 135

Gene expression profiling data related to antioxidant defense mechanisms in ischemic rat brain following green tea extract administration, including Nrf2, HO-1, and NQO1 transcript levels.

Figure 136

Comparison of green tea extract versus pentoxifylline efficacy on composite neurological outcomes after cerebral ischemia, indicating comparable or superior neuroprotection from the natural compound.

Figure 137

Fluorescent imaging of reactive oxygen species in live hippocampal slices from ischemic rats, with DCF-DA probe revealing reduced oxidative burden in EGCG-pretreated tissue.

Figure 138

References and supplementary materials from the green tea extract neuroprotection study, documenting the complete citation list for the investigation.

Figure 139

Tissue preparation and staining protocol details for the histological analyses performed throughout the green tea extract cerebral ischemia study.

Figure 140

Final summary data panel integrating oxidative stress reduction, anti-inflammatory effects, and cognitive preservation outcomes attributed to green tea extract and EGCG in the ischemic rat model.

Figure 141

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 142

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 143

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 144

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 145

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 146

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 147

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 148

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 149

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 150

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 151

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 152

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 153

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 154

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 155

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 156

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 157

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 158

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 159

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 160

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 161

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 162

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 163

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 164

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 165

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 166

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 167

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 168

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 169

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 170

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 171

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 172

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 173

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 174

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 175

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 176

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 177

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 178

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 179

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 180

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 181

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 182

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 183

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 184

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 185

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 186

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 187

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 188

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 189

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 190

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 191

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 192

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 193

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 194

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 195

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 196

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 197

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 198

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 199

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 200

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 201

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 202

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 203

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 204

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 205

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 206

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 207

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 208

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 209

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 210

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 211

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 212

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 213

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 214

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 215

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 216

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 217

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 218

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 219

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 220

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 221

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 222

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 223

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 224

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 225

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 226

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 227

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 228

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 229

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 230

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 231

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 232

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 233

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 234

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 235

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 236

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 237

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 238

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 239

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 240

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 241

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 242

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 243

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 244

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 245

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 246

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 247

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 248

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 249

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 250

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 251

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 252

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 253

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 254

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 255

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 256

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 257

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 258

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 259

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 260

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 261

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 262

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 263

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 264

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 265

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 266

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 267

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 268

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 269

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 270

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 271

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 272

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 273

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 274

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 275

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 276

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 277

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 278

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 279

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 280

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 281

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 282

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 283

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 284

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 285

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 286

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 287

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 288

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 289

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 290

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 291

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 292

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 293

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 294

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 295

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 296

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 297

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 298

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 299

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 300

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 301

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 302

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 303

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 304

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 305

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 306

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 307

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 308

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 309

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 310

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 311

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 312

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 313

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 314

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 315

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 316

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 317

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 318

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 319

Antioxidant enzyme activity in ischemic rat brain tissue is quantified across experimental groups. Glutathione levels and superoxide dismutase (SOD) activity indicate that green tea extract and EGCG may attenuate oxidative damage associated with cerebral ischemia.

Figure 320

Neuroinflammatory markers are assessed in this panel from the ischemic stroke study. The data suggest that EGCG, the major polyphenol in green tea extract, modulates inflammatory responses in the brain following ischemic injury, comparable to the reference drug pentoxifylline.

Figure 321

Behavioral assessment data from the Morris water maze test demonstrate spatial learning and memory performance in cerebral ischemic rats. Animals receiving green tea extract or EGCG pretreatment showed improved escape latency and time spent in the target quadrant.

Figure 322

Catalase activity and related oxidative stress parameters in brain tissue are shown for different treatment groups in this ischemic stroke model. Green tea polyphenols, particularly EGCG, are associated with preservation of endogenous antioxidant defense mechanisms.

Figure 323

A panel from the green tea extract (GTex) and EGCG study in ischemic rats presents data related to Morris water maze performance. GTex and EGCG administration before middle cerebral artery ligation significantly improved ischemia-induced memory impairment compared with untreated controls.

Figure 324

Oxidative stress markers in cerebral ischemic rats are displayed following treatment with green tea extract or EGCG. Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured across treatment groups to assess the antioxidant effects of these polyphenol compounds.

Figure 325

Brain tissue sections from ischemic rats illustrate the neuroprotective effects of green tea polyphenols. Histological analysis reveals differences in neuronal damage between GTex/EGCG-treated and vehicle-treated groups following middle cerebral artery occlusion.

Figure 326

Escape latency measurements from the Morris water maze test indicate that rats treated with green tea extract (GTex) and EGCG demonstrated significantly improved spatial learning compared to the ischemic control group.

Figure 327

Swimming path length data from the Morris water maze reveal that EGCG-treated ischemic rats navigated more efficiently to the platform, suggesting preserved spatial memory function.

Figure 328

Time spent in the target quadrant during the Morris water maze probe trial was significantly greater in GTex-treated rats, indicating enhanced memory retention following cerebral ischemia.

Figure 329

Latency to reach the hidden platform across training days shows a steeper learning curve in EGCG and pentoxifylline (PTX) groups compared to untreated ischemic rats.

Figure 330

Representative swimming trajectories from the Morris water maze demonstrate more directed search patterns in green tea extract-treated rats versus erratic paths in ischemic controls.

Figure 331

Malondialdehyde (MDA) levels in brain tissue homogenates were markedly reduced in rats receiving green tea extract pretreatment, suggesting attenuation of lipid peroxidation after ischemic injury.

Figure 332

Comparison of MDA concentrations across treatment groups indicates that both GTex and EGCG significantly decreased oxidative stress markers relative to the ischemia-only group.

Figure 333

Brain tissue MDA levels measured at different time points post-ischemia show sustained antioxidant effects in the EGCG-treated group compared to vehicle controls.

Figure 334

Superoxide dismutase (SOD) activity in brain homogenates was significantly preserved in GTex-treated ischemic rats, indicating protection of endogenous antioxidant defenses.

Figure 335

Catalase enzyme activity levels across experimental groups demonstrate that EGCG pretreatment maintained antioxidant capacity following middle cerebral artery occlusion.

Figure 336

Glutathione peroxidase (GPx) activity measurements reveal that green tea polyphenols helped maintain redox balance in ischemic brain tissue.

Figure 337

Pro-inflammatory cytokine levels (TNF-alpha, IL-1beta) in ischemic brain tissue were significantly lower in rats pretreated with EGCG, suggesting anti-neuroinflammatory effects.

Figure 338

NF-kappaB expression levels in brain tissue sections indicate reduced inflammatory signaling in the green tea extract treatment group following cerebral ischemia.

Figure 339

Quantification of inflammatory cell infiltration shows fewer activated microglia in EGCG-treated rats compared to the ischemic control group.

Figure 340

COX-2 expression measured by Western blot analysis was attenuated in GTex-treated ischemic rats, consistent with reduced neuroinflammation.

Figure 341

Coronal brain section from a sham-operated rat shows intact neuronal architecture in the hippocampal CA1 region with no signs of ischemic damage.

Figure 342

Histological section of hippocampal tissue from an ischemic control rat reveals extensive neuronal cell death and pyknotic nuclei in the CA1 subfield.

Figure 343

Brain tissue section from an EGCG-treated rat shows preserved hippocampal neuronal morphology with markedly less ischemic damage compared to untreated controls.

Figure 344

Nissl-stained hippocampal sections demonstrate significantly more surviving neurons in the CA1 region of GTex-treated rats following cerebral ischemia.

Figure 345

Higher magnification view of the hippocampal CA1 region reveals intact pyramidal cell layers in green tea extract-treated ischemic rats.

Figure 346

Representative brain section showing the extent of infarct area, with TTC staining revealing reduced infarct volume in the EGCG pretreatment group.

Figure 347

Cortical tissue section from an ischemic rat displays marked neuronal degeneration, characterized by shrunken cell bodies and darkly stained nuclei.

Figure 348

Immunohistochemical staining for GFAP in the peri-infarct region shows reduced astrocyte activation in GTex-treated rats.

Figure 349

Western blot bands for phospho-Akt and total Akt in hippocampal lysates suggest activation of the PI3K/Akt survival pathway in EGCG-treated ischemic rats.

Figure 350

Densitometric analysis of Western blot data shows significantly increased Bcl-2/Bax ratio in green tea extract-treated rats, indicating anti-apoptotic signaling.

Figure 351

Protein expression levels of iNOS and COX-2 measured by immunoblotting were reduced in the EGCG group, supporting the anti-inflammatory mechanism of green tea polyphenols.

Figure 352

Western blot analysis of NF-kappaB p65 subunit translocation reveals attenuated nuclear accumulation in GTex-pretreated ischemic brain tissue.

Figure 353

Infarct volume quantification by TTC staining demonstrates a significant reduction in brain infarct size in rats receiving green tea extract prior to middle cerebral artery ligation.

Figure 354

Representative TTC-stained coronal brain slices from each experimental group illustrate the dose-dependent neuroprotective effect of EGCG on infarct size.

Figure 355

Bar graph comparing mean infarct volumes shows that both GTex and EGCG treatments resulted in significantly smaller ischemic lesions than vehicle control.

Figure 356

TUNEL staining of hippocampal sections reveals fewer apoptotic neurons in the EGCG-treated group, suggesting neuroprotection against ischemia-induced cell death.

Figure 357

Quantification of TUNEL-positive cells in the peri-infarct cortex indicates that green tea extract pretreatment significantly reduced neuronal apoptosis.

Figure 358

Caspase-3 immunoreactivity in the ischemic penumbra was markedly reduced in GTex-treated rats, consistent with attenuated apoptotic signaling.

Figure 359

Neurological deficit scores assessed at 24 hours post-ischemia were significantly lower in the EGCG and GTex groups, indicating better functional outcomes.

Figure 360

Composite neurological function scores across treatment groups demonstrate dose-dependent improvement with EGCG administration before ischemic injury.

Figure 361

Body weight changes over the experimental period show that green tea extract-treated rats maintained closer-to-normal weight compared to untreated ischemic animals.

Figure 362

Experimental timeline illustrating the sequence of green tea extract administration, middle cerebral artery ligation, and behavioral testing in the Morris water maze.

Figure 363

Schematic diagram of the study design showing group allocation, treatment protocol, and outcome measurement timepoints for the cerebral ischemia model.

Figure 364

Regional cerebral blood flow measurements indicate that EGCG pretreatment did not significantly alter perfusion patterns during middle cerebral artery occlusion.

Figure 365

Immunofluorescence staining of brain tissue shows reduced microglial activation (Iba-1 positive cells) in the peri-infarct region of GTex-treated rats.

Figure 366

Quantitative analysis of surviving neurons in the hippocampal CA1 region reveals a significantly higher neuronal density in EGCG-treated versus ischemic control animals.

Figure 367

Dose-response relationship between EGCG concentration and MDA reduction suggests optimal neuroprotection at the tested pretreatment dose.

Figure 368

Representative photomicrographs of Fluoro-Jade B staining demonstrate fewer degenerating neurons in the cortex of green tea extract-treated ischemic rats.

Figure 369

Brain edema quantification based on wet-dry weight ratios indicates reduced cerebral swelling in the EGCG pretreatment group following ischemia.

Figure 370

Correlation analysis between escape latency in the Morris water maze and hippocampal MDA levels suggests that oxidative stress is associated with memory impairment severity.

Figure 371

Cytochrome c release from mitochondria was attenuated in the EGCG group, as shown by Western blot analysis of cytosolic and mitochondrial fractions.

Figure 372

Heat map of gene expression changes in the ischemic penumbra reveals upregulation of antioxidant response elements in GTex-pretreated rats.

Figure 373

Comparative analysis of platform crossings during the probe trial indicates significantly better spatial memory recall in both EGCG and PTX groups.

Figure 374

Immunohistochemical detection of 8-OHdG (oxidative DNA damage marker) shows reduced nuclear staining intensity in hippocampal neurons of EGCG-treated rats.

Figure 375

Total antioxidant capacity (TAC) measurements in brain tissue demonstrate preservation of redox homeostasis with green tea extract pretreatment.

Figure 376

Escape latency measurements from the Morris water maze test indicate that rats treated with green tea extract (GTex) and EGCG demonstrated significantly improved spatial learning compared to the ischemic control group.

Figure 377

Swimming path length data from the Morris water maze reveal that EGCG-treated ischemic rats navigated more efficiently to the platform, suggesting preserved spatial memory function.

Figure 378

Time spent in the target quadrant during the Morris water maze probe trial was significantly greater in GTex-treated rats, indicating enhanced memory retention following cerebral ischemia.

Figure 379

Latency to reach the hidden platform across training days shows a steeper learning curve in EGCG and pentoxifylline (PTX) groups compared to untreated ischemic rats.

Figure 380

Representative swimming trajectories from the Morris water maze demonstrate more directed search patterns in green tea extract-treated rats versus erratic paths in ischemic controls.

Figure 381

Malondialdehyde (MDA) levels in brain tissue homogenates were markedly reduced in rats receiving green tea extract pretreatment, suggesting attenuation of lipid peroxidation after ischemic injury.

Figure 382

Comparison of MDA concentrations across treatment groups indicates that both GTex and EGCG significantly decreased oxidative stress markers relative to the ischemia-only group.

Figure 383

Brain tissue MDA levels measured at different time points post-ischemia show sustained antioxidant effects in the EGCG-treated group compared to vehicle controls.

Figure 384

Superoxide dismutase (SOD) activity in brain homogenates was significantly preserved in GTex-treated ischemic rats, indicating protection of endogenous antioxidant defenses.

Figure 385

Catalase enzyme activity levels across experimental groups demonstrate that EGCG pretreatment maintained antioxidant capacity following middle cerebral artery occlusion.

Figure 386

Glutathione peroxidase (GPx) activity measurements reveal that green tea polyphenols helped maintain redox balance in ischemic brain tissue.

Figure 387

Pro-inflammatory cytokine levels (TNF-alpha, IL-1beta) in ischemic brain tissue were significantly lower in rats pretreated with EGCG, suggesting anti-neuroinflammatory effects.

Figure 388

NF-kappaB expression levels in brain tissue sections indicate reduced inflammatory signaling in the green tea extract treatment group following cerebral ischemia.

Figure 389

Quantification of inflammatory cell infiltration shows fewer activated microglia in EGCG-treated rats compared to the ischemic control group.

Figure 390

COX-2 expression measured by Western blot analysis was attenuated in GTex-treated ischemic rats, consistent with reduced neuroinflammation.

Figure 391

Coronal brain section from a sham-operated rat shows intact neuronal architecture in the hippocampal CA1 region with no signs of ischemic damage.

Figure 392

Histological section of hippocampal tissue from an ischemic control rat reveals extensive neuronal cell death and pyknotic nuclei in the CA1 subfield.

Figure 393

Brain tissue section from an EGCG-treated rat shows preserved hippocampal neuronal morphology with markedly less ischemic damage compared to untreated controls.

Figure 394

Nissl-stained hippocampal sections demonstrate significantly more surviving neurons in the CA1 region of GTex-treated rats following cerebral ischemia.

Figure 395

Higher magnification view of the hippocampal CA1 region reveals intact pyramidal cell layers in green tea extract-treated ischemic rats.

Figure 396

Representative brain section showing the extent of infarct area, with TTC staining revealing reduced infarct volume in the EGCG pretreatment group.

Figure 397

Cortical tissue section from an ischemic rat displays marked neuronal degeneration, characterized by shrunken cell bodies and darkly stained nuclei.

Figure 398

Immunohistochemical staining for GFAP in the peri-infarct region shows reduced astrocyte activation in GTex-treated rats.

Figure 399

Western blot bands for phospho-Akt and total Akt in hippocampal lysates suggest activation of the PI3K/Akt survival pathway in EGCG-treated ischemic rats.

Figure 400

Densitometric analysis of Western blot data shows significantly increased Bcl-2/Bax ratio in green tea extract-treated rats, indicating anti-apoptotic signaling.

Figure 401

Protein expression levels of iNOS and COX-2 measured by immunoblotting were reduced in the EGCG group, supporting the anti-inflammatory mechanism of green tea polyphenols.

Figure 402

Western blot analysis of NF-kappaB p65 subunit translocation reveals attenuated nuclear accumulation in GTex-pretreated ischemic brain tissue.

Figure 403

Infarct volume quantification by TTC staining demonstrates a significant reduction in brain infarct size in rats receiving green tea extract prior to middle cerebral artery ligation.

Figure 404

Representative TTC-stained coronal brain slices from each experimental group illustrate the dose-dependent neuroprotective effect of EGCG on infarct size.

Figure 405

Bar graph comparing mean infarct volumes shows that both GTex and EGCG treatments resulted in significantly smaller ischemic lesions than vehicle control.

Figure 406

TUNEL staining of hippocampal sections reveals fewer apoptotic neurons in the EGCG-treated group, suggesting neuroprotection against ischemia-induced cell death.

Figure 407

Quantification of TUNEL-positive cells in the peri-infarct cortex indicates that green tea extract pretreatment significantly reduced neuronal apoptosis.

Figure 408

Caspase-3 immunoreactivity in the ischemic penumbra was markedly reduced in GTex-treated rats, consistent with attenuated apoptotic signaling.

Figure 409

Neurological deficit scores assessed at 24 hours post-ischemia were significantly lower in the EGCG and GTex groups, indicating better functional outcomes.

Figure 410

Composite neurological function scores across treatment groups demonstrate dose-dependent improvement with EGCG administration before ischemic injury.

Figure 411

Body weight changes over the experimental period show that green tea extract-treated rats maintained closer-to-normal weight compared to untreated ischemic animals.

Figure 412

Experimental timeline illustrating the sequence of green tea extract administration, middle cerebral artery ligation, and behavioral testing in the Morris water maze.

Figure 413

Schematic diagram of the study design showing group allocation, treatment protocol, and outcome measurement timepoints for the cerebral ischemia model.

Figure 414

Regional cerebral blood flow measurements indicate that EGCG pretreatment did not significantly alter perfusion patterns during middle cerebral artery occlusion.

Figure 415

Immunofluorescence staining of brain tissue shows reduced microglial activation (Iba-1 positive cells) in the peri-infarct region of GTex-treated rats.

Figure 416

Quantitative analysis of surviving neurons in the hippocampal CA1 region reveals a significantly higher neuronal density in EGCG-treated versus ischemic control animals.

Figure 417

Dose-response relationship between EGCG concentration and MDA reduction suggests optimal neuroprotection at the tested pretreatment dose.

Figure 418

Representative photomicrographs of Fluoro-Jade B staining demonstrate fewer degenerating neurons in the cortex of green tea extract-treated ischemic rats.

Figure 419

Brain edema quantification based on wet-dry weight ratios indicates reduced cerebral swelling in the EGCG pretreatment group following ischemia.

Figure 420

Correlation analysis between escape latency in the Morris water maze and hippocampal MDA levels suggests that oxidative stress is associated with memory impairment severity.

Figure 421

Cytochrome c release from mitochondria was attenuated in the EGCG group, as shown by Western blot analysis of cytosolic and mitochondrial fractions.

Figure 422

Heat map of gene expression changes in the ischemic penumbra reveals upregulation of antioxidant response elements in GTex-pretreated rats.

Figure 423

Comparative analysis of platform crossings during the probe trial indicates significantly better spatial memory recall in both EGCG and PTX groups.

Figure 424

Immunohistochemical detection of 8-OHdG (oxidative DNA damage marker) shows reduced nuclear staining intensity in hippocampal neurons of EGCG-treated rats.

Figure 425

Total antioxidant capacity (TAC) measurements in brain tissue demonstrate preservation of redox homeostasis with green tea extract pretreatment.

Figure 426

Escape latency measurements from the Morris water maze test indicate that rats treated with green tea extract (GTex) and EGCG demonstrated significantly improved spatial learning compared to the ischemic control group.

Figure 427

Swimming path length data from the Morris water maze reveal that EGCG-treated ischemic rats navigated more efficiently to the platform, suggesting preserved spatial memory function.

Figure 428

Time spent in the target quadrant during the Morris water maze probe trial was significantly greater in GTex-treated rats, indicating enhanced memory retention following cerebral ischemia.

Figure 429

Latency to reach the hidden platform across training days shows a steeper learning curve in EGCG and pentoxifylline (PTX) groups compared to untreated ischemic rats.

Figure 430

Representative swimming trajectories from the Morris water maze demonstrate more directed search patterns in green tea extract-treated rats versus erratic paths in ischemic controls.

Figure 431

Malondialdehyde (MDA) levels in brain tissue homogenates were markedly reduced in rats receiving green tea extract pretreatment, suggesting attenuation of lipid peroxidation after ischemic injury.

Figure 432

Comparison of MDA concentrations across treatment groups indicates that both GTex and EGCG significantly decreased oxidative stress markers relative to the ischemia-only group.

Figure 433

Brain tissue MDA levels measured at different time points post-ischemia show sustained antioxidant effects in the EGCG-treated group compared to vehicle controls.

Figure 434

Superoxide dismutase (SOD) activity in brain homogenates was significantly preserved in GTex-treated ischemic rats, indicating protection of endogenous antioxidant defenses.

Figure 435

Catalase enzyme activity levels across experimental groups demonstrate that EGCG pretreatment maintained antioxidant capacity following middle cerebral artery occlusion.

Figure 436

Glutathione peroxidase (GPx) activity measurements reveal that green tea polyphenols helped maintain redox balance in ischemic brain tissue.

Figure 437

Pro-inflammatory cytokine levels (TNF-alpha, IL-1beta) in ischemic brain tissue were significantly lower in rats pretreated with EGCG, suggesting anti-neuroinflammatory effects.

Figure 438

NF-kappaB expression levels in brain tissue sections indicate reduced inflammatory signaling in the green tea extract treatment group following cerebral ischemia.

Figure 439

Quantification of inflammatory cell infiltration shows fewer activated microglia in EGCG-treated rats compared to the ischemic control group.

Figure 440

COX-2 expression measured by Western blot analysis was attenuated in GTex-treated ischemic rats, consistent with reduced neuroinflammation.

Figure 441

Coronal brain section from a sham-operated rat shows intact neuronal architecture in the hippocampal CA1 region with no signs of ischemic damage.

Figure 442

Histological section of hippocampal tissue from an ischemic control rat reveals extensive neuronal cell death and pyknotic nuclei in the CA1 subfield.

Figure 443

Brain tissue section from an EGCG-treated rat shows preserved hippocampal neuronal morphology with markedly less ischemic damage compared to untreated controls.

Figure 444

Nissl-stained hippocampal sections demonstrate significantly more surviving neurons in the CA1 region of GTex-treated rats following cerebral ischemia.

Figure 445

Higher magnification view of the hippocampal CA1 region reveals intact pyramidal cell layers in green tea extract-treated ischemic rats.

Figure 446

Representative brain section showing the extent of infarct area, with TTC staining revealing reduced infarct volume in the EGCG pretreatment group.

Figure 447

Cortical tissue section from an ischemic rat displays marked neuronal degeneration, characterized by shrunken cell bodies and darkly stained nuclei.

Figure 448

Immunohistochemical staining for GFAP in the peri-infarct region shows reduced astrocyte activation in GTex-treated rats.

Figure 449

Western blot bands for phospho-Akt and total Akt in hippocampal lysates suggest activation of the PI3K/Akt survival pathway in EGCG-treated ischemic rats.

Figure 450

Densitometric analysis of Western blot data shows significantly increased Bcl-2/Bax ratio in green tea extract-treated rats, indicating anti-apoptotic signaling.

Figure 451

Protein expression levels of iNOS and COX-2 measured by immunoblotting were reduced in the EGCG group, supporting the anti-inflammatory mechanism of green tea polyphenols.

Figure 452

Western blot analysis of NF-kappaB p65 subunit translocation reveals attenuated nuclear accumulation in GTex-pretreated ischemic brain tissue.

Figure 453

Infarct volume quantification by TTC staining demonstrates a significant reduction in brain infarct size in rats receiving green tea extract prior to middle cerebral artery ligation.

Figure 454

Representative TTC-stained coronal brain slices from each experimental group illustrate the dose-dependent neuroprotective effect of EGCG on infarct size.

Figure 455

Bar graph comparing mean infarct volumes shows that both GTex and EGCG treatments resulted in significantly smaller ischemic lesions than vehicle control.

Figure 456

TUNEL staining of hippocampal sections reveals fewer apoptotic neurons in the EGCG-treated group, suggesting neuroprotection against ischemia-induced cell death.

Figure 457

Quantification of TUNEL-positive cells in the peri-infarct cortex indicates that green tea extract pretreatment significantly reduced neuronal apoptosis.

Figure 458

Caspase-3 immunoreactivity in the ischemic penumbra was markedly reduced in GTex-treated rats, consistent with attenuated apoptotic signaling.

Figure 459

Neurological deficit scores assessed at 24 hours post-ischemia were significantly lower in the EGCG and GTex groups, indicating better functional outcomes.

Figure 460

Composite neurological function scores across treatment groups demonstrate dose-dependent improvement with EGCG administration before ischemic injury.

Figure 461

Body weight changes over the experimental period show that green tea extract-treated rats maintained closer-to-normal weight compared to untreated ischemic animals.

Figure 462

Experimental timeline illustrating the sequence of green tea extract administration, middle cerebral artery ligation, and behavioral testing in the Morris water maze.

Figure 463

Schematic diagram of the study design showing group allocation, treatment protocol, and outcome measurement timepoints for the cerebral ischemia model.

Figure 464

Regional cerebral blood flow measurements indicate that EGCG pretreatment did not significantly alter perfusion patterns during middle cerebral artery occlusion.

Figure 465

Immunofluorescence staining of brain tissue shows reduced microglial activation (Iba-1 positive cells) in the peri-infarct region of GTex-treated rats.

Figure 466

Quantitative analysis of surviving neurons in the hippocampal CA1 region reveals a significantly higher neuronal density in EGCG-treated versus ischemic control animals.

Figure 467

Dose-response relationship between EGCG concentration and MDA reduction suggests optimal neuroprotection at the tested pretreatment dose.

Figure 468

Representative photomicrographs of Fluoro-Jade B staining demonstrate fewer degenerating neurons in the cortex of green tea extract-treated ischemic rats.

Figure 469

Brain edema quantification based on wet-dry weight ratios indicates reduced cerebral swelling in the EGCG pretreatment group following ischemia.

Figure 470

Correlation analysis between escape latency in the Morris water maze and hippocampal MDA levels suggests that oxidative stress is associated with memory impairment severity.

Figure 471

Cytochrome c release from mitochondria was attenuated in the EGCG group, as shown by Western blot analysis of cytosolic and mitochondrial fractions.

Figure 472

Heat map of gene expression changes in the ischemic penumbra reveals upregulation of antioxidant response elements in GTex-pretreated rats.

Figure 473

Comparative analysis of platform crossings during the probe trial indicates significantly better spatial memory recall in both EGCG and PTX groups.

Figure 474

Immunohistochemical detection of 8-OHdG (oxidative DNA damage marker) shows reduced nuclear staining intensity in hippocampal neurons of EGCG-treated rats.

Figure 475

Total antioxidant capacity (TAC) measurements in brain tissue demonstrate preservation of redox homeostasis with green tea extract pretreatment.

Figure 476

Escape latency measurements from the Morris water maze test indicate that rats treated with green tea extract (GTex) and EGCG demonstrated significantly improved spatial learning compared to the ischemic control group.

Figure 477

Swimming path length data from the Morris water maze reveal that EGCG-treated ischemic rats navigated more efficiently to the platform, suggesting preserved spatial memory function.

Figure 478

Time spent in the target quadrant during the Morris water maze probe trial was significantly greater in GTex-treated rats, indicating enhanced memory retention following cerebral ischemia.

Figure 479

Latency to reach the hidden platform across training days shows a steeper learning curve in EGCG and pentoxifylline (PTX) groups compared to untreated ischemic rats.

Figure 480

Representative swimming trajectories from the Morris water maze demonstrate more directed search patterns in green tea extract-treated rats versus erratic paths in ischemic controls.

Figure 481

Malondialdehyde (MDA) levels in brain tissue homogenates were markedly reduced in rats receiving green tea extract pretreatment, suggesting attenuation of lipid peroxidation after ischemic injury.

Figure 482

Comparison of MDA concentrations across treatment groups indicates that both GTex and EGCG significantly decreased oxidative stress markers relative to the ischemia-only group.

Figure 483

Brain tissue MDA levels measured at different time points post-ischemia show sustained antioxidant effects in the EGCG-treated group compared to vehicle controls.

Figure 484

Superoxide dismutase (SOD) activity in brain homogenates was significantly preserved in GTex-treated ischemic rats, indicating protection of endogenous antioxidant defenses.

Figure 485

Catalase enzyme activity levels across experimental groups demonstrate that EGCG pretreatment maintained antioxidant capacity following middle cerebral artery occlusion.

Figure 486

Glutathione peroxidase (GPx) activity measurements reveal that green tea polyphenols helped maintain redox balance in ischemic brain tissue.

Figure 487

Pro-inflammatory cytokine levels (TNF-alpha, IL-1beta) in ischemic brain tissue were significantly lower in rats pretreated with EGCG, suggesting anti-neuroinflammatory effects.

Figure 488

NF-kappaB expression levels in brain tissue sections indicate reduced inflammatory signaling in the green tea extract treatment group following cerebral ischemia.

Figure 489

Quantification of inflammatory cell infiltration shows fewer activated microglia in EGCG-treated rats compared to the ischemic control group.

Figure 490

COX-2 expression measured by Western blot analysis was attenuated in GTex-treated ischemic rats, consistent with reduced neuroinflammation.

Figure 491

Coronal brain section from a sham-operated rat shows intact neuronal architecture in the hippocampal CA1 region with no signs of ischemic damage.

Figure 492

Histological section of hippocampal tissue from an ischemic control rat reveals extensive neuronal cell death and pyknotic nuclei in the CA1 subfield.

Figure 493

Brain tissue section from an EGCG-treated rat shows preserved hippocampal neuronal morphology with markedly less ischemic damage compared to untreated controls.

Figure 494

Nissl-stained hippocampal sections demonstrate significantly more surviving neurons in the CA1 region of GTex-treated rats following cerebral ischemia.

Figure 495

Higher magnification view of the hippocampal CA1 region reveals intact pyramidal cell layers in green tea extract-treated ischemic rats.

Figure 496

Representative brain section showing the extent of infarct area, with TTC staining revealing reduced infarct volume in the EGCG pretreatment group.

Figure 497

Cortical tissue section from an ischemic rat displays marked neuronal degeneration, characterized by shrunken cell bodies and darkly stained nuclei.

Figure 498

Immunohistochemical staining for GFAP in the peri-infarct region shows reduced astrocyte activation in GTex-treated rats.

Figure 499

Western blot bands for phospho-Akt and total Akt in hippocampal lysates suggest activation of the PI3K/Akt survival pathway in EGCG-treated ischemic rats.

Figure 500

Densitometric analysis of Western blot data shows significantly increased Bcl-2/Bax ratio in green tea extract-treated rats, indicating anti-apoptotic signaling.

Figure 501

Protein expression levels of iNOS and COX-2 measured by immunoblotting were reduced in the EGCG group, supporting the anti-inflammatory mechanism of green tea polyphenols.

Figure 502

Western blot analysis of NF-kappaB p65 subunit translocation reveals attenuated nuclear accumulation in GTex-pretreated ischemic brain tissue.

Figure 503

Infarct volume quantification by TTC staining demonstrates a significant reduction in brain infarct size in rats receiving green tea extract prior to middle cerebral artery ligation.

Figure 504

Representative TTC-stained coronal brain slices from each experimental group illustrate the dose-dependent neuroprotective effect of EGCG on infarct size.

Figure 505

Bar graph comparing mean infarct volumes shows that both GTex and EGCG treatments resulted in significantly smaller ischemic lesions than vehicle control.

Figure 506

TUNEL staining of hippocampal sections reveals fewer apoptotic neurons in the EGCG-treated group, suggesting neuroprotection against ischemia-induced cell death.

Figure 507

Quantification of TUNEL-positive cells in the peri-infarct cortex indicates that green tea extract pretreatment significantly reduced neuronal apoptosis.

Figure 508

Caspase-3 immunoreactivity in the ischemic penumbra was markedly reduced in GTex-treated rats, consistent with attenuated apoptotic signaling.

Figure 509

Neurological deficit scores assessed at 24 hours post-ischemia were significantly lower in the EGCG and GTex groups, indicating better functional outcomes.

Figure 510

Composite neurological function scores across treatment groups demonstrate dose-dependent improvement with EGCG administration before ischemic injury.

Figure 511

Body weight changes over the experimental period show that green tea extract-treated rats maintained closer-to-normal weight compared to untreated ischemic animals.

Figure 512

Experimental timeline illustrating the sequence of green tea extract administration, middle cerebral artery ligation, and behavioral testing in the Morris water maze.

Figure 513

Schematic diagram of the study design showing group allocation, treatment protocol, and outcome measurement timepoints for the cerebral ischemia model.

Figure 514

Regional cerebral blood flow measurements indicate that EGCG pretreatment did not significantly alter perfusion patterns during middle cerebral artery occlusion.

Figure 515

Immunofluorescence staining of brain tissue shows reduced microglial activation (Iba-1 positive cells) in the peri-infarct region of GTex-treated rats.

Figure 516

Quantitative analysis of surviving neurons in the hippocampal CA1 region reveals a significantly higher neuronal density in EGCG-treated versus ischemic control animals.

Figure 517

Dose-response relationship between EGCG concentration and MDA reduction suggests optimal neuroprotection at the tested pretreatment dose.

Figure 518

Representative photomicrographs of Fluoro-Jade B staining demonstrate fewer degenerating neurons in the cortex of green tea extract-treated ischemic rats.

Figure 519

Brain edema quantification based on wet-dry weight ratios indicates reduced cerebral swelling in the EGCG pretreatment group following ischemia.

Figure 520

Correlation analysis between escape latency in the Morris water maze and hippocampal MDA levels suggests that oxidative stress is associated with memory impairment severity.

Figure 521

Cytochrome c release from mitochondria was attenuated in the EGCG group, as shown by Western blot analysis of cytosolic and mitochondrial fractions.

Figure 522

Heat map of gene expression changes in the ischemic penumbra reveals upregulation of antioxidant response elements in GTex-pretreated rats.

Figure 523

Comparative analysis of platform crossings during the probe trial indicates significantly better spatial memory recall in both EGCG and PTX groups.

Figure 524

Immunohistochemical detection of 8-OHdG (oxidative DNA damage marker) shows reduced nuclear staining intensity in hippocampal neurons of EGCG-treated rats.

Figure 525

Total antioxidant capacity (TAC) measurements in brain tissue demonstrate preservation of redox homeostasis with green tea extract pretreatment.

Figure 526

Escape latency measurements from the Morris water maze test indicate that rats treated with green tea extract (GTex) and EGCG demonstrated significantly improved spatial learning compared to the ischemic control group.

Figure 527

Swimming path length data from the Morris water maze reveal that EGCG-treated ischemic rats navigated more efficiently to the platform, suggesting preserved spatial memory function.

Figure 528

Time spent in the target quadrant during the Morris water maze probe trial was significantly greater in GTex-treated rats, indicating enhanced memory retention following cerebral ischemia.

Figure 529

Latency to reach the hidden platform across training days shows a steeper learning curve in EGCG and pentoxifylline (PTX) groups compared to untreated ischemic rats.

Figure 530

Representative swimming trajectories from the Morris water maze demonstrate more directed search patterns in green tea extract-treated rats versus erratic paths in ischemic controls.

Figure 531

Malondialdehyde (MDA) levels in brain tissue homogenates were markedly reduced in rats receiving green tea extract pretreatment, suggesting attenuation of lipid peroxidation after ischemic injury.

Figure 532

Comparison of MDA concentrations across treatment groups indicates that both GTex and EGCG significantly decreased oxidative stress markers relative to the ischemia-only group.

Figure 533

Brain tissue MDA levels measured at different time points post-ischemia show sustained antioxidant effects in the EGCG-treated group compared to vehicle controls.

Figure 534

Superoxide dismutase (SOD) activity in brain homogenates was significantly preserved in GTex-treated ischemic rats, indicating protection of endogenous antioxidant defenses.

Figure 535

Catalase enzyme activity levels across experimental groups demonstrate that EGCG pretreatment maintained antioxidant capacity following middle cerebral artery occlusion.

Figure 536

Glutathione peroxidase (GPx) activity measurements reveal that green tea polyphenols helped maintain redox balance in ischemic brain tissue.

Figure 537

Pro-inflammatory cytokine levels (TNF-alpha, IL-1beta) in ischemic brain tissue were significantly lower in rats pretreated with EGCG, suggesting anti-neuroinflammatory effects.

Figure 538

NF-kappaB expression levels in brain tissue sections indicate reduced inflammatory signaling in the green tea extract treatment group following cerebral ischemia.

Figure 539

Quantification of inflammatory cell infiltration shows fewer activated microglia in EGCG-treated rats compared to the ischemic control group.

Figure 540

COX-2 expression measured by Western blot analysis was attenuated in GTex-treated ischemic rats, consistent with reduced neuroinflammation.

Figure 541

Coronal brain section from a sham-operated rat shows intact neuronal architecture in the hippocampal CA1 region with no signs of ischemic damage.

Figure 542

Histological section of hippocampal tissue from an ischemic control rat reveals extensive neuronal cell death and pyknotic nuclei in the CA1 subfield.

Figure 543

Brain tissue section from an EGCG-treated rat shows preserved hippocampal neuronal morphology with markedly less ischemic damage compared to untreated controls.

Figure 544

Nissl-stained hippocampal sections demonstrate significantly more surviving neurons in the CA1 region of GTex-treated rats following cerebral ischemia.

Figure 545

Higher magnification view of the hippocampal CA1 region reveals intact pyramidal cell layers in green tea extract-treated ischemic rats.

Figure 546

Representative brain section showing the extent of infarct area, with TTC staining revealing reduced infarct volume in the EGCG pretreatment group.

Figure 547

Cortical tissue section from an ischemic rat displays marked neuronal degeneration, characterized by shrunken cell bodies and darkly stained nuclei.

Figure 548

Immunohistochemical staining for GFAP in the peri-infarct region shows reduced astrocyte activation in GTex-treated rats.

Figure 549

Western blot bands for phospho-Akt and total Akt in hippocampal lysates suggest activation of the PI3K/Akt survival pathway in EGCG-treated ischemic rats.

Figure 550

Densitometric analysis of Western blot data shows significantly increased Bcl-2/Bax ratio in green tea extract-treated rats, indicating anti-apoptotic signaling.

Figure 551

Protein expression levels of iNOS and COX-2 measured by immunoblotting were reduced in the EGCG group, supporting the anti-inflammatory mechanism of green tea polyphenols.

Figure 552

Western blot analysis of NF-kappaB p65 subunit translocation reveals attenuated nuclear accumulation in GTex-pretreated ischemic brain tissue.

Figure 553

Infarct volume quantification by TTC staining demonstrates a significant reduction in brain infarct size in rats receiving green tea extract prior to middle cerebral artery ligation.

Figure 554

Representative TTC-stained coronal brain slices from each experimental group illustrate the dose-dependent neuroprotective effect of EGCG on infarct size.

Figure 555

Bar graph comparing mean infarct volumes shows that both GTex and EGCG treatments resulted in significantly smaller ischemic lesions than vehicle control.

Figure 556

TUNEL staining of hippocampal sections reveals fewer apoptotic neurons in the EGCG-treated group, suggesting neuroprotection against ischemia-induced cell death.

Figure 557

Quantification of TUNEL-positive cells in the peri-infarct cortex indicates that green tea extract pretreatment significantly reduced neuronal apoptosis.

Figure 558

Caspase-3 immunoreactivity in the ischemic penumbra was markedly reduced in GTex-treated rats, consistent with attenuated apoptotic signaling.

Figure 559

Neurological deficit scores assessed at 24 hours post-ischemia were significantly lower in the EGCG and GTex groups, indicating better functional outcomes.

Figure 560

Composite neurological function scores across treatment groups demonstrate dose-dependent improvement with EGCG administration before ischemic injury.

Figure 561

Body weight changes over the experimental period show that green tea extract-treated rats maintained closer-to-normal weight compared to untreated ischemic animals.

Figure 562

Experimental timeline illustrating the sequence of green tea extract administration, middle cerebral artery ligation, and behavioral testing in the Morris water maze.

Figure 563

Schematic diagram of the study design showing group allocation, treatment protocol, and outcome measurement timepoints for the cerebral ischemia model.

Figure 564

Regional cerebral blood flow measurements indicate that EGCG pretreatment did not significantly alter perfusion patterns during middle cerebral artery occlusion.

Figure 565

Immunofluorescence staining of brain tissue shows reduced microglial activation (Iba-1 positive cells) in the peri-infarct region of GTex-treated rats.

Figure 566

Quantitative analysis of surviving neurons in the hippocampal CA1 region reveals a significantly higher neuronal density in EGCG-treated versus ischemic control animals.

Figure 567

Dose-response relationship between EGCG concentration and MDA reduction suggests optimal neuroprotection at the tested pretreatment dose.

Figure 568

Representative photomicrographs of Fluoro-Jade B staining demonstrate fewer degenerating neurons in the cortex of green tea extract-treated ischemic rats.

Figure 569

Brain edema quantification based on wet-dry weight ratios indicates reduced cerebral swelling in the EGCG pretreatment group following ischemia.

Figure 570

Correlation analysis between escape latency in the Morris water maze and hippocampal MDA levels suggests that oxidative stress is associated with memory impairment severity.

Figure 571

Cytochrome c release from mitochondria was attenuated in the EGCG group, as shown by Western blot analysis of cytosolic and mitochondrial fractions.

Figure 572

Heat map of gene expression changes in the ischemic penumbra reveals upregulation of antioxidant response elements in GTex-pretreated rats.

Figure 573

Comparative analysis of platform crossings during the probe trial indicates significantly better spatial memory recall in both EGCG and PTX groups.

Figure 574

Immunohistochemical detection of 8-OHdG (oxidative DNA damage marker) shows reduced nuclear staining intensity in hippocampal neurons of EGCG-treated rats.

Figure 575

Total antioxidant capacity (TAC) measurements in brain tissue demonstrate preservation of redox homeostasis with green tea extract pretreatment.

Figure 576

Behavioral assessment data from ischemic rats treated with green tea extract (GTex) or EGCG, evaluating learning and memory performance after cerebral ischemia induction.

Figure 577

Quantitative analysis of memory function in rats following ischemic stroke, comparing green tea extract and EGCG treatment groups against vehicle controls.

Figure 578

Morris water maze performance metrics for ischemic rats, illustrating spatial learning and memory outcomes across green tea polyphenol treatment conditions.

Figure 579

Oxidative stress biomarker levels in brain tissue of ischemic rats, measuring the antioxidant effects of green tea extract and EGCG supplementation.

Figure 580

Measurement of reactive oxygen species and lipid peroxidation markers in cerebral tissue, comparing EGCG-treated and untreated ischemic rat groups.

Figure 581

Antioxidant enzyme activity levels in brain homogenates from ischemic rats receiving green tea extract or EGCG treatment.

Figure 582

Neuroinflammatory marker expression in ischemic brain tissue, assessing the anti-inflammatory properties of EGCG and green tea extract.

Figure 583

Pro-inflammatory cytokine levels measured in brain tissue following cerebral ischemia, with and without green tea polyphenol intervention.

Figure 584

Inflammatory pathway activation analysis in ischemic rat brain, demonstrating modulation by green tea extract components.

Figure 585

Histological examination of brain tissue from ischemic rats, comparing neuronal damage between green tea extract-treated and control groups.

Figure 586

Brain tissue section showing the extent of ischemic damage and neuronal preservation in rats treated with EGCG.

Figure 587

Microscopic analysis of cerebral cortex tissue, illustrating the neuroprotective effects of green tea polyphenols against ischemic injury.

Figure 588

Western blot or protein expression analysis from ischemic rat brain tissue, evaluating molecular targets of green tea extract and EGCG.

Figure 589

Signaling pathway protein quantification in brain tissue, showing how EGCG modulates oxidative stress and inflammatory cascades after ischemia.

Figure 590

Gene or protein expression data from cerebral tissue of ischemic rats, comparing the molecular effects of green tea extract treatment.

Figure 591

Experimental data from the ischemic stroke rat model examining the dose-dependent neuroprotective effects of green tea polyphenol EGCG.

Figure 592

Quantitative outcome measures from rats with induced cerebral ischemia, comparing green tea extract efficacy in reducing brain damage.

Figure 593

Biochemical analysis of brain tissue parameters in ischemic rats, supporting the therapeutic potential of green tea-derived EGCG.

Figure 594

Assessment of neurological deficit scores in ischemic rats across treatment groups receiving green tea extract or purified EGCG.

Figure 595

Comparative analysis of cerebral infarct volume or edema in rats treated with green tea extract versus vehicle following ischemic injury.

Figure 596

Behavioral assessment data from ischemic rats treated with green tea extract (GTex) or EGCG, evaluating learning and memory performance after cerebral ischemia induction.

Figure 597

Quantitative analysis of memory function in rats following ischemic stroke, comparing green tea extract and EGCG treatment groups against vehicle controls.

Figure 598

Morris water maze performance metrics for ischemic rats, illustrating spatial learning and memory outcomes across green tea polyphenol treatment conditions.

Figure 599

Oxidative stress biomarker levels in brain tissue of ischemic rats, measuring the antioxidant effects of green tea extract and EGCG supplementation.

Figure 600

Measurement of reactive oxygen species and lipid peroxidation markers in cerebral tissue, comparing EGCG-treated and untreated ischemic rat groups.

Figure 601

Antioxidant enzyme activity levels in brain homogenates from ischemic rats receiving green tea extract or EGCG treatment.

Figure 602

Neuroinflammatory marker expression in ischemic brain tissue, assessing the anti-inflammatory properties of EGCG and green tea extract.

Figure 603

Pro-inflammatory cytokine levels measured in brain tissue following cerebral ischemia, with and without green tea polyphenol intervention.

Figure 604

Inflammatory pathway activation analysis in ischemic rat brain, demonstrating modulation by green tea extract components.

Figure 605

Histological examination of brain tissue from ischemic rats, comparing neuronal damage between green tea extract-treated and control groups.

Figure 606

Brain tissue section showing the extent of ischemic damage and neuronal preservation in rats treated with EGCG.

Figure 607

Microscopic analysis of cerebral cortex tissue, illustrating the neuroprotective effects of green tea polyphenols against ischemic injury.

Figure 608

Western blot or protein expression analysis from ischemic rat brain tissue, evaluating molecular targets of green tea extract and EGCG.

Figure 609

Signaling pathway protein quantification in brain tissue, showing how EGCG modulates oxidative stress and inflammatory cascades after ischemia.

Figure 610

Gene or protein expression data from cerebral tissue of ischemic rats, comparing the molecular effects of green tea extract treatment.

Figure 611

Experimental data from the ischemic stroke rat model examining the dose-dependent neuroprotective effects of green tea polyphenol EGCG.

Figure 612

Quantitative outcome measures from rats with induced cerebral ischemia, comparing green tea extract efficacy in reducing brain damage.

Figure 613

Biochemical analysis of brain tissue parameters in ischemic rats, supporting the therapeutic potential of green tea-derived EGCG.

Figure 614

Assessment of neurological deficit scores in ischemic rats across treatment groups receiving green tea extract or purified EGCG.

Figure 615

Comparative analysis of cerebral infarct volume or edema in rats treated with green tea extract versus vehicle following ischemic injury.

Figure 616

Behavioral assessment data from ischemic rats treated with green tea extract (GTex) or EGCG, evaluating learning and memory performance after cerebral ischemia induction.

Figure 617

Quantitative analysis of memory function in rats following ischemic stroke, comparing green tea extract and EGCG treatment groups against vehicle controls.

Figure 618

Morris water maze performance metrics for ischemic rats, illustrating spatial learning and memory outcomes across green tea polyphenol treatment conditions.

Figure 619

Oxidative stress biomarker levels in brain tissue of ischemic rats, measuring the antioxidant effects of green tea extract and EGCG supplementation.

Figure 620

Measurement of reactive oxygen species and lipid peroxidation markers in cerebral tissue, comparing EGCG-treated and untreated ischemic rat groups.

Figure 621

Antioxidant enzyme activity levels in brain homogenates from ischemic rats receiving green tea extract or EGCG treatment.

Figure 622

Neuroinflammatory marker expression in ischemic brain tissue, assessing the anti-inflammatory properties of EGCG and green tea extract.

Figure 623

Pro-inflammatory cytokine levels measured in brain tissue following cerebral ischemia, with and without green tea polyphenol intervention.

Figure 624

Inflammatory pathway activation analysis in ischemic rat brain, demonstrating modulation by green tea extract components.

Figure 625

Histological examination of brain tissue from ischemic rats, comparing neuronal damage between green tea extract-treated and control groups.

Figure 626

Brain tissue section showing the extent of ischemic damage and neuronal preservation in rats treated with EGCG.

Figure 627

Microscopic analysis of cerebral cortex tissue, illustrating the neuroprotective effects of green tea polyphenols against ischemic injury.

Figure 628

Western blot or protein expression analysis from ischemic rat brain tissue, evaluating molecular targets of green tea extract and EGCG.

Figure 629

Signaling pathway protein quantification in brain tissue, showing how EGCG modulates oxidative stress and inflammatory cascades after ischemia.

Figure 630

Gene or protein expression data from cerebral tissue of ischemic rats, comparing the molecular effects of green tea extract treatment.

Figure 631

Experimental data from the ischemic stroke rat model examining the dose-dependent neuroprotective effects of green tea polyphenol EGCG.

Figure 632

Quantitative outcome measures from rats with induced cerebral ischemia, comparing green tea extract efficacy in reducing brain damage.

Figure 633

Biochemical analysis of brain tissue parameters in ischemic rats, supporting the therapeutic potential of green tea-derived EGCG.

Figure 634

Assessment of neurological deficit scores in ischemic rats across treatment groups receiving green tea extract or purified EGCG.

Figure 635

Comparative analysis of cerebral infarct volume or edema in rats treated with green tea extract versus vehicle following ischemic injury.

Figure 636

Behavioral assessment data from ischemic rats treated with green tea extract (GTex) or EGCG, evaluating learning and memory performance after cerebral ischemia induction.

Figure 637

Quantitative analysis of memory function in rats following ischemic stroke, comparing green tea extract and EGCG treatment groups against vehicle controls.

Figure 638

Morris water maze performance metrics for ischemic rats, illustrating spatial learning and memory outcomes across green tea polyphenol treatment conditions.

Figure 639

Oxidative stress biomarker levels in brain tissue of ischemic rats, measuring the antioxidant effects of green tea extract and EGCG supplementation.

Figure 640

Measurement of reactive oxygen species and lipid peroxidation markers in cerebral tissue, comparing EGCG-treated and untreated ischemic rat groups.

Figure 641

Antioxidant enzyme activity levels in brain homogenates from ischemic rats receiving green tea extract or EGCG treatment.

Figure 642

Neuroinflammatory marker expression in ischemic brain tissue, assessing the anti-inflammatory properties of EGCG and green tea extract.

Figure 643

Pro-inflammatory cytokine levels measured in brain tissue following cerebral ischemia, with and without green tea polyphenol intervention.

Figure 644

Inflammatory pathway activation analysis in ischemic rat brain, demonstrating modulation by green tea extract components.

Figure 645

Histological examination of brain tissue from ischemic rats, comparing neuronal damage between green tea extract-treated and control groups.

Figure 646

Brain tissue section showing the extent of ischemic damage and neuronal preservation in rats treated with EGCG.

Figure 647

Microscopic analysis of cerebral cortex tissue, illustrating the neuroprotective effects of green tea polyphenols against ischemic injury.

Figure 648

Western blot or protein expression analysis from ischemic rat brain tissue, evaluating molecular targets of green tea extract and EGCG.

Figure 649

Signaling pathway protein quantification in brain tissue, showing how EGCG modulates oxidative stress and inflammatory cascades after ischemia.

Figure 650

Gene or protein expression data from cerebral tissue of ischemic rats, comparing the molecular effects of green tea extract treatment.

Figure 651

Experimental data from the ischemic stroke rat model examining the dose-dependent neuroprotective effects of green tea polyphenol EGCG.

Figure 652

Quantitative outcome measures from rats with induced cerebral ischemia, comparing green tea extract efficacy in reducing brain damage.

Figure 653

Biochemical analysis of brain tissue parameters in ischemic rats, supporting the therapeutic potential of green tea-derived EGCG.

Figure 654

Assessment of neurological deficit scores in ischemic rats across treatment groups receiving green tea extract or purified EGCG.

Figure 655

Comparative analysis of cerebral infarct volume or edema in rats treated with green tea extract versus vehicle following ischemic injury.

Figure 656

Behavioral assessment data from ischemic rats treated with green tea extract (GTex) or EGCG, evaluating learning and memory performance after cerebral ischemia induction.

Figure 657

Quantitative analysis of memory function in rats following ischemic stroke, comparing green tea extract and EGCG treatment groups against vehicle controls.

Figure 658

Morris water maze performance metrics for ischemic rats, illustrating spatial learning and memory outcomes across green tea polyphenol treatment conditions.

Figure 659

Oxidative stress biomarker levels in brain tissue of ischemic rats, measuring the antioxidant effects of green tea extract and EGCG supplementation.

Figure 660

Measurement of reactive oxygen species and lipid peroxidation markers in cerebral tissue, comparing EGCG-treated and untreated ischemic rat groups.

Figure 661

Antioxidant enzyme activity levels in brain homogenates from ischemic rats receiving green tea extract or EGCG treatment.

Figure 662

Neuroinflammatory marker expression in ischemic brain tissue, assessing the anti-inflammatory properties of EGCG and green tea extract.

Figure 663

Pro-inflammatory cytokine levels measured in brain tissue following cerebral ischemia, with and without green tea polyphenol intervention.

Figure 664

Inflammatory pathway activation analysis in ischemic rat brain, demonstrating modulation by green tea extract components.

Figure 665

Histological examination of brain tissue from ischemic rats, comparing neuronal damage between green tea extract-treated and control groups.

Figure 666

Brain tissue section showing the extent of ischemic damage and neuronal preservation in rats treated with EGCG.

Figure 667

Microscopic analysis of cerebral cortex tissue, illustrating the neuroprotective effects of green tea polyphenols against ischemic injury.

Figure 668

Western blot or protein expression analysis from ischemic rat brain tissue, evaluating molecular targets of green tea extract and EGCG.

Figure 669

Signaling pathway protein quantification in brain tissue, showing how EGCG modulates oxidative stress and inflammatory cascades after ischemia.

Figure 670

Gene or protein expression data from cerebral tissue of ischemic rats, comparing the molecular effects of green tea extract treatment.

Figure 671

Experimental data from the ischemic stroke rat model examining the dose-dependent neuroprotective effects of green tea polyphenol EGCG.

Figure 672

Quantitative outcome measures from rats with induced cerebral ischemia, comparing green tea extract efficacy in reducing brain damage.

Figure 673

Biochemical analysis of brain tissue parameters in ischemic rats, supporting the therapeutic potential of green tea-derived EGCG.

Figure 674

Assessment of neurological deficit scores in ischemic rats across treatment groups receiving green tea extract or purified EGCG.

Figure 675

Comparative analysis of cerebral infarct volume or edema in rats treated with green tea extract versus vehicle following ischemic injury.

Figure 676

Behavioral assessment data from ischemic rats treated with green tea extract (GTex) or EGCG, evaluating learning and memory performance after cerebral ischemia induction.

Figure 677

Quantitative analysis of memory function in rats following ischemic stroke, comparing green tea extract and EGCG treatment groups against vehicle controls.

Figure 678

Morris water maze performance metrics for ischemic rats, illustrating spatial learning and memory outcomes across green tea polyphenol treatment conditions.

Figure 679

Oxidative stress biomarker levels in brain tissue of ischemic rats, measuring the antioxidant effects of green tea extract and EGCG supplementation.

Figure 680

Measurement of reactive oxygen species and lipid peroxidation markers in cerebral tissue, comparing EGCG-treated and untreated ischemic rat groups.

Figure 681

Antioxidant enzyme activity levels in brain homogenates from ischemic rats receiving green tea extract or EGCG treatment.

Figure 682

Neuroinflammatory marker expression in ischemic brain tissue, assessing the anti-inflammatory properties of EGCG and green tea extract.

Figure 683

Pro-inflammatory cytokine levels measured in brain tissue following cerebral ischemia, with and without green tea polyphenol intervention.

Figure 684

Inflammatory pathway activation analysis in ischemic rat brain, demonstrating modulation by green tea extract components.

Figure 685

Histological examination of brain tissue from ischemic rats, comparing neuronal damage between green tea extract-treated and control groups.

Figure 686

Brain tissue section showing the extent of ischemic damage and neuronal preservation in rats treated with EGCG.

Figure 687

Microscopic analysis of cerebral cortex tissue, illustrating the neuroprotective effects of green tea polyphenols against ischemic injury.